Gabriela Ecco
Board Member at Notify Therapeutics
Gabriela Ecco
Board Member at Notify Therapeutics
Lausanne, Vaud
Overview
Work Experience
Board Observer
2023 - Current
Senior Associate
2023
Associate
2021 - 2022
Innovation Fellow
2021 - 2021
NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.
Board Observer
2022
Board Observer
2022
Board Observer
2021
Board Observer
2021
Board Observer
2021 - 2022
Genomics Research Expert
2020 - 2021
- Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.
Senior NGS Scientist
2019 - 2020
- Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.
NGS Scientist
2016 - 2019
- Coordinated and participated in different projects to develop products for precision medicine and molecular diagnostics in oncology. - Performed on-site customer trainings in Europe and South America and provided internal and external technical support.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Raised $265,152,150.00 from Perceptive Advisors.
Research Assistant
2011 - 2016
Development of a large-scale functional screen to determine the function of KRAB-ZFP transcription factors, and biological validation of candidates in early embryogenesis and in somatic tissues (PhD advisor: Prof Didier Trono).
Summer Intern
2015 - 2015
Evaluated the effects of hydrogels in cartilage tissue engineering at Prof Tsuyoshi Takato laboratory.